As of 2:35pm ET
| -1.09 / -5.81%|
The 13 analysts offering 12-month price forecasts for Cellectis SA have a median target of 40.00, with a high estimate of 73.00 and a low estimate of 21.00. The median estimate represents a +127.47% increase from the last price of 17.59.
The current consensus among 9 polled investment analysts is to Buy stock in Cellectis SA. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.